Lupus & antiphospholipid syndrome

Analysis of clinical, immunological characteristics, damage, and survival in 300 Turkish systemic lupus erythematosus patients

LupusPublished Retrospective cohort study

Authors' conclusion

Ethnicity and geography influence the clinical diversity of SLE.

Study context

Population
Systemic Lupus Erythematosus (SLE) patients of Caucasian ethnicity diagnosed 2001–2017 at Kocaeli University Rheumatology Clinic, Turkey
Participants
300 patients
Outcome
Clinical, immunological characteristics, damage and survival
Methodological detailssingle-centre
  • Single-centre

Main finding

As reported in the abstract

Female
89%
Mean age of disease onset (SD 13.3), years
35.4
Hematological manifestations
72.6%
Mucocutaneous manifestations
72%
Arthritis
66.3%
Anti-dsDNA antibodies
61.6%
Hypocomplementemia
57%
Secondary APS
15.3%
Lupus Nephritis (LN)
40.3%
Class IV LN (most common pathologic finding)
30.5%
Chronic kidney disease (CKD) (n = 13); 4 had renal replacement therapies
4.3%
At least one damage parameter (musculoskeletal most common)
32.6%
Malignancies, patients (cervical cancer most common, 4 cases)
13
5-year survival
92.5%
10-year survival
86.7%

Observational data: associations, not effects.

Further findings

Manifestations of secondary APS

DVT
32.6%
Cerebrovascular accidents
30.4%

Females vs males: mucocutaneous features

Females had higher frequency of photosensitivity
P = 0.019
Females had higher frequency of malar rash
P < 0.001
Females had higher frequency of alopecia
P = 0.014

Treatment in patients with LN

Higher usage of pulse steroids, AZA, MMF, CYC and RTX in LN
P < 0.001 for each

Juvenile-onset SLE (n = 31, 10.3%) (subgroup)

Increased malar rash
P = 0.009
Increased nephritis
P = 0.034
Increased hypocomplementemia
P = 0.001
Increased positive anti-dsDNA
P = 0.007
Increased anti-Sm
P = 0.046
Increased anti-rib-P
P = 0.014

Survival in patients with CKD

Survival at 3 years
75%
Survival at 15 years
60%
CKD and history of infections associated with decreased survival (regression analysis)
P = 0.02, each

Original publication

Analysis of clinical, immunological characteristics, damage, and survival in 300 Turkish systemic lupus erythematosus patients. Lupus. Published 23 January 2024. doi:10.1177/09612033241228174

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.